Delivery Order SPE2DB24D2205-SPE2DB25FEAPY
Award Date
4/7/25
Potential Completion Date
4/8/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,005.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,517,461 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets, with a completion date of November 22, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated with any set-aside requirements, indicating open...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a total ceiling value of $2,015.40 and a performance period ending on April 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,312.38 firm fixed-price delivery order is for the supply of 4,567,279,022 units of Pantoprazole Sodium Delayed-Release 40 mg tablets, a medication used to treat conditions such as gastroesophageal reflux disease (GERD). The contract has an ultimate completion date of February 18, 2025 and was awarded on...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,565,644,526 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The $1,415.98 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of September 3, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $5,872.98, is for the delivery of Pantoprazole Sodium Delayed-Release (DR) 40 mg tablets in 1,000-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of February 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $2,663.15 for the provision of 4,567,828,723 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has an ultimate completion date of April 8, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,113.04 firm fixed-price delivery order is for the supply of 4,567,752,489 units of Pantoprazole Sodium Delayed-Release 40 mg tablets, with a period of performance through April 1, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,571.30, is for the delivery of 4,567,909,043 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 15, 2025. The award did not have a set-aside designation, indicating open competition....
This federal contract award, valued at $1,432.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pantoprazole Sodium Delayed-Release Tablets, 40 mg, in 1,000-count bottles. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award, valued at $1,362.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pantoprazole Sodium Delayed-Release Tablets, 40 mg, in quantities of 1,000. The contract was awarded on July 22, 2024, and has an ultimate completion date of July 23, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. There is no...